The identification of microglia subpopulations associated with amyloid-β and tau pathology suggests that these cells exhibit unique phenotypic and metabolic characteristics, highlighting the complexity of microglia and their impact on AD disease progression. The gene discussed is MAPT; the disease is Alzheimer disease.